Search results
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 1 day agoAccording to the Centers for Disease Control and Prevention (CDC), nearly 20 million Americans over ...
Dear Doctor: Can I use over-the-counter eye drops while on medications for macular degeneration?
OregonLive.com· 2 days agoROACH: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
FOX 23 News Albany· 4 days agoThe study enrolled patients with newly diagnosed wet AMD and active choroidal neovascularization (CNV), where anti-VEGF therapy was indicated.
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
NBC 17 Raleigh· 5 days agoPharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that ...
2 Small-Cap Growth Stocks With Room to Run
Motley Fool via Yahoo Finance· 3 days agoTherapeutix is a specialist in eye diseases. Currently, Wall Street analysts believe the company's shares could be undervalued by as much as 210%. The...
Ocugen (NASDAQ:OCGN) Given New $5.00 Price Target at Chardan Capital
ETF DAILY NEWS· 6 days agoOcugen (NASDAQ:OCGN – Get Free Report) had its price objective increased by stock analysts at Chardan Capital from $4.00 to $5.00 in a research report issued on Monday, Benzinga reports. Chardan ...
Cwm LLC Sells 256 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 2 days agoCwm LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...
RWA Wealth Partners LLC Invests $375,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 2 days agoRWA Wealth Partners LLC acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing ...
Mirae Asset Global Investments Co. Ltd. Reduces Holdings in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 7 days agoMirae Asset Global Investments Co. Ltd. trimmed its position in shares of REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 54.7% in the 4th quarter, according to its most recent disclosure with ...
StockNews.com Downgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Buy
ETF DAILY NEWS· 6 days agoSeveral other research analysts have also weighed in on REGN. Truist Financial restated a “buy” rating and set a $1,135.00 price objective on shares of Regeneron Pharmaceuticals in a research ...